There are 449 resources available
166P - Impact of immunotherapy (IT) on overall survival (OS) of patients with malignant pleural mesothelioma (MPM) adjusted for tumor histology
Presenter: Susana Cedres
Session: Poster Display session
167P - Copy number intratumour heterogeneity in the context of metastatic seeding
Presenter: Shania Makker
Session: Poster Display session
168P - Validation of lung specific and lung molecular graded prognostic assessment score in metastatic NSCLC with brain metastases from India
Presenter: Anil Tibdewal
Session: Poster Display session
169P - Genomic landscape of NSCLC brain metastases and its potential association with TP53 and tumor mutation burden: A territory-wide program in Hong Kong
Presenter: Tsz Yeung Kam
Session: Poster Display session
170P - Change in the epidemiology and costs of metastatic lung cancer in France between 2013 and 2021: Observational study using the SNDS
Presenter: Gérard de Pouvourville
Session: Poster Display session
171P - Systematic review-based treatment algorithm for multidisciplinary treatment of lung cancer bone metastases
Presenter: Chai Hong Rim
Session: Poster Display session
172P - Real-world data of anolotinib for lung cancers with liver metastases in China
Presenter: Minglei Zhuo
Session: Poster Display session
173P - Surgery versus stereotactic body radiation therapy as initial treatment for pulmonary oligometastases from colorectal cancer: A propensity score analysis
Presenter: Yaqi Wang
Session: Poster Display session
175P - Quality of life in patients with NSCLC brain metastases undergoing different local therapies in the era of precision oncology: A territory-wide study
Presenter: Charlene Hoi Lam Wong
Session: Poster Display session